Overview
Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis
Status:
Completed
Completed
Trial end date:
2013-08-01
2013-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is a prospective, non-interventional, cross-sectional multicenter survey. The aim is to better understand the current therapy pattern for anemia in CKD treated with erythropoiesis-stimulating agents (ESAs) and not on-dialysis participant population in Israel. Participating physicians will be requested to interview eligible participants with CKD not on dialysis and to complete for them a satisfaction survey for anemia treatment. The survey will be completed twice, once at study start and once at six months' follow-up.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hoffmann-La Roche
Criteria
Inclusion Criteria:- Adult participants with CKD Stage 3-5
- Treated with ESAs
- Participant is speaking the same language as the investigator interviewer
Exclusion Criteria:
- Past or current treatment with dialysis